These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 1487402)
1. Clinical pharmacology studies of oltipraz--a potential chemopreventive agent. Dimitrov NV; Bennett JL; McMillan J; Perloff M; Leece CM; Malone W Invest New Drugs; 1992 Nov; 10(4):289-98. PubMed ID: 1487402 [TBL] [Abstract][Full Text] [Related]
2. Oltipraz: a laboratory and clinical review. Benson AB J Cell Biochem Suppl; 1993; 17F():278-91. PubMed ID: 8412206 [TBL] [Abstract][Full Text] [Related]
3. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases. Primiano T; Egner PA; Sutter TR; Kelloff GJ; Roebuck BD; Kensler TW Cancer Res; 1995 Oct; 55(19):4319-24. PubMed ID: 7671242 [TBL] [Abstract][Full Text] [Related]
4. Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients. Benson AB; Olopade OI; Ratain MJ; Rademaker A; Mobarhan S; Stucky-Marshall L; French S; Dolan ME Clin Cancer Res; 2000 Oct; 6(10):3870-7. PubMed ID: 11051232 [TBL] [Abstract][Full Text] [Related]
5. Oltipraz concentrations in plasma, buccal mucosa cells, and lipids: pharmacological studies. Dimitrov NV; Leece CM; Tompkins ER; Seymour E; Bennink M; Gardiner J; Crowell J; Hawk E; Nashawaty M; Bennett JL Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):201-7. PubMed ID: 11303588 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz. Scholl P; Musser SM; Kensler TW; Groopman JD Carcinogenesis; 1996 Jun; 17(6):1385-8. PubMed ID: 8681461 [TBL] [Abstract][Full Text] [Related]
7. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells. O'Dwyer PJ; Clayton M; Halbherr T; Myers CB; Yao Ks Clin Cancer Res; 1997 May; 3(5):783-91. PubMed ID: 9815750 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent. Gupta E; Olopade OI; Ratain MJ; Mick R; Baker TM; Berezin FK; Benson AB; Dolan ME Clin Cancer Res; 1995 Oct; 1(10):1133-8. PubMed ID: 9815904 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the chemopreventive agent oltipraz and of its metabolite M3 in human subjects after a single oral dose. O'Dwyer PJ; Szarka C; Brennan JM; Laub PB; Gallo JM Clin Cancer Res; 2000 Dec; 6(12):4692-6. PubMed ID: 11156221 [TBL] [Abstract][Full Text] [Related]
11. Protection of retinal pigment epithelial cells from oxidative damage by oltipraz, a cancer chemopreventive agent. Nelson KC; Armstrong JS; Moriarty S; Cai J; Wu MW; Sternberg P; Jones DP Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3550-4. PubMed ID: 12407167 [TBL] [Abstract][Full Text] [Related]
12. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers. Kensler TW; He X; Otieno M; Egner PA; Jacobson LP; Chen B; Wang JS; Zhu YR; Zhang BC; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Fang X; Li YF; Yu LY; Prochaska HJ; Davidson NE; Gordon GB; Gorman MB; Zarba A; Enger C; Muñoz A; Helzlsouer KJ Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):127-34. PubMed ID: 9488587 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver. Davidson NE; Egner PA; Kensler TW Cancer Res; 1990 Apr; 50(8):2251-5. PubMed ID: 2317812 [TBL] [Abstract][Full Text] [Related]
14. Chemoprevention by inducers of carcinogen detoxication enzymes. Kensler TW Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):965-70. PubMed ID: 9255588 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of mitogen-activated protein kinase activity of human lymphocytes after oral administration of Oltipraz. Madhukar BV; Dimitrov NV; Meyer-Leece C; Contreras ML; Crowell J Mol Cancer Ther; 2002 Oct; 1(12):1125-8. PubMed ID: 12481436 [TBL] [Abstract][Full Text] [Related]
16. Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz. Egner PA; Gange SJ; Dolan PM; Groopman JD; Muñoz A; Kensler TW Carcinogenesis; 1995 Aug; 16(8):1769-73. PubMed ID: 7634402 [TBL] [Abstract][Full Text] [Related]